Amniotic membrane-mesenchymal stromal cells secreted factors and extracellular vesicle-miRNAs: Anti-inflammatory and regenerative features for musculoskeletal tissues.


Journal

Stem cells translational medicine
ISSN: 2157-6580
Titre abrégé: Stem Cells Transl Med
Pays: England
ID NLM: 101578022

Informations de publication

Date de publication:
07 2021
Historique:
revised: 17 12 2020
received: 19 08 2020
accepted: 18 01 2021
pubmed: 4 3 2021
medline: 24 3 2022
entrez: 3 3 2021
Statut: ppublish

Résumé

Human amniotic membrane-derived mesenchymal stromal cells (hAMSCs) are easily obtained in large quantities and free from ethical concerns. Promising therapeutic results for both hAMSCs and their secreted factors (secretome) were described by several in vitro and preclinical studies, often for treatment of orthopedic disorders such as osteoarthritis (OA) and tendinopathy. For clinical translation of the hAMSC secretome as cell-free therapy, a detailed characterization of hAMSC-secreted factors is mandatory. Herein, we tested the presence of 200 secreted factors and 754 miRNAs in extracellular vesicles (EVs). Thirty-seven cytokines/chemokines were identified at varying abundance, some of which involved in both chemotaxis and homeostasis of inflammatory cells and in positive remodeling of extracellular matrix, often damaged in tendinopathy and OA. We also found 336 EV-miRNAs, 51 of which accounted for more than 95% of the genetic message. A focused analysis based on miRNAs related to OA and tendinopathy showed that most abundant EV-miRNAs are teno- and chondro-protective, able to induce M2 macrophage polarization, inhibit inflammatory T cells, and promote Treg. Functional analysis on IL-1β treated tenocytes and chondrocytes resulted in downregulation of inflammation-associated genes. Overall, presence of key regulatory molecules and miRNAs explain the promising therapeutic results of hAMSCs and their secretome for treatment of musculoskeletal conditions and are a groundwork for similar studies in other pathologies. Furthermore, identified molecules will pave the way for future studies aimed at more sharply predicting disease-targeted clinical efficacy, as well as setting up potency and release assays to fingerprint clinical-grade batches of whole secretome or purified components.

Identifiants

pubmed: 33656805
doi: 10.1002/sctm.20-0390
pmc: PMC8235131
doi:

Substances chimiques

Chemokines 0
Cytokines 0
MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1044-1062

Informations de copyright

© 2021 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals LLC on behalf of AlphaMed Press.

Références

Arthritis Rheumatol. 2014 Feb;66(2):327-39
pubmed: 24504805
Biomed Pharmacother. 2016 Apr;79:159-65
pubmed: 27044824
Mol Med Rep. 2019 May;19(5):4388-4400
pubmed: 30942441
Eplasty. 2013 Jun 19;13:e31
pubmed: 23814634
Front Immunol. 2017 Mar 30;8:356
pubmed: 28424692
Acta Cir Bras. 2017 Feb;32(2):125-139
pubmed: 28300874
Am J Pathol. 2005 Mar;166(3):783-92
pubmed: 15743790
Osteoarthritis Cartilage. 1999 May;7(3):308-9
pubmed: 10329308
Cell Commun Signal. 2016 Jan 12;14:2
pubmed: 26754424
J Orthop Translat. 2018 Apr 14;14:23-33
pubmed: 30035030
Stem Cells Transl Med. 2020 Jan;9(1):17-27
pubmed: 31804767
Cell. 2010 Sep 17;142(6):914-29
pubmed: 20850013
Int J Mol Sci. 2019 Sep 17;20(18):
pubmed: 31533317
Semin Cell Dev Biol. 2017 Jul;67:56-64
pubmed: 27871993
J Knee Surg. 2016 Aug;29(6):443-50
pubmed: 26683979
J Orthop Res. 2002 Sep;20(5):927-33
pubmed: 12382955
Osteoarthritis Cartilage. 2000 Jan;8(1):25-33
pubmed: 10607496
NPJ Regen Med. 2019 Apr 16;4:8
pubmed: 31016031
Immunity. 2011 Aug 26;35(2):169-81
pubmed: 21820330
Clin Immunol. 2002 Dec;105(3):315-25
pubmed: 12498813
Am J Hematol. 2015 Nov;90(11):998-1007
pubmed: 26223969
J Extracell Vesicles. 2019 Apr 29;8(1):1609206
pubmed: 31069028
Osteoarthritis Cartilage. 2006 Nov;14(11):1136-46
pubmed: 16730198
Front Immunol. 2020 Jun 09;11:1156
pubmed: 32582218
Osteoarthritis Cartilage. 2002 Jul;10(7):556-63
pubmed: 12127836
J Leukoc Biol. 2015 Aug;98(2):195-207
pubmed: 25990241
Muscles Ligaments Tendons J. 2016 Feb 12;6(4):445-452
pubmed: 28217565
Cell Transplant. 2015;24(9):1733-52
pubmed: 25259480
J Tissue Eng Regen Med. 2017 Oct;11(10):2895-2911
pubmed: 27396853
Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv44-7
pubmed: 16239386
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
Stem Cells Transl Med. 2021 Jul;10(7):1044-1062
pubmed: 33656805
Methods Mol Biol. 2012;822:261-72
pubmed: 22144205
Osteoarthritis Cartilage. 2002 Apr;10(4):277-81
pubmed: 11950250
Arthritis Rheum. 2011 Sep;63(9):2732-43
pubmed: 21590680
Scand J Med Sci Sports. 2005 Aug;15(4):241-51
pubmed: 15998341
Hum Immunol. 2014 Jul;75(7):677-85
pubmed: 24704866
Scand J Med Sci Sports. 2005 Aug;15(4):252-9
pubmed: 15998342
Cell Transplant. 2017 Apr 13;26(4):531-539
pubmed: 27938500
Stem Cell Investig. 2019 Sep 25;6:34
pubmed: 31620481
Ann Rheum Dis. 2016 Apr;76(4):748-755
pubmed: 27789465
Front Immunol. 2019 Sep 13;10:2217
pubmed: 31572403
Oncotarget. 2016 Jul 12;7(28):43076-43087
pubmed: 27172798
J Orthop Surg Res. 2017 Mar 28;12(1):51
pubmed: 28351380
Biochem J. 1986 Dec 1;240(2):423-30
pubmed: 3545187
PLoS One. 2012;7(10):e46956
pubmed: 23071674
Muscles Ligaments Tendons J. 2013 May 21;3(1):51-7
pubmed: 23885345
Stem Cells. 2017 Apr;35(4):1093-1105
pubmed: 28164431
Cytotherapy. 2014 Jan;16(1):17-32
pubmed: 24094500
Cells. 2019 Nov 08;8(11):
pubmed: 31717431
Stem Cell Res Ther. 2019 Mar 29;10(1):109
pubmed: 30922413
Mol Cell Biochem. 2018 Jan;437(1-2):81-97
pubmed: 28634854
Crit Care Med. 2016 Nov;44(11):e1118-e1131
pubmed: 27441900
J Tissue Eng. 2013 Jun 09;4:2041731413492741
pubmed: 23762501
J Shoulder Elbow Surg. 2010 Apr;19(3):384-91
pubmed: 19800260
J Orthop Res. 2006 Feb;24(2):183-92
pubmed: 16435347
EMBO J. 2015 May 5;34(9):1195-213
pubmed: 25712478
Exp Ther Med. 2017 Jul;14(1):187-192
pubmed: 28672913
Int Orthop. 2021 Feb;45(2):419-426
pubmed: 32642826
J Orthop Res. 2003 Sep;21(5):819-25
pubmed: 12919869
J Vet Sci. 2011 Sep;12(3):273-80
pubmed: 21897101
Osteoarthritis Cartilage. 2012 Dec;20(12):1484-99
pubmed: 22960092
Cell Transplant. 2009;18(4):405-22
pubmed: 19622228
Stem Cells Int. 2018 Jun 14;2018:3057624
pubmed: 30013600
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Gene. 2011 Jul 1;480(1-2):34-41
pubmed: 21397669
Einstein (Sao Paulo). 2015 Jul-Sep;13(3):469-73
pubmed: 26466066
J Musculoskelet Neuronal Interact. 2006 Apr-Jun;6(2):181-90
pubmed: 16849830
PLoS One. 2012;7(7):e41105
pubmed: 22815931
J Extracell Vesicles. 2013 Jan 10;2:
pubmed: 24009896
JCI Insight. 2018 Sep 6;3(17):
pubmed: 30185670
Cell Transplant. 2015;24(12):2601-14
pubmed: 25812083
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14888-93
pubmed: 25267620
Stem Cell Rev Rep. 2015 Jun;11(3):394-407
pubmed: 25348066
Vet J. 2009 Feb;179(2):211-8
pubmed: 17938000
Cells. 2019 Sep 24;8(10):
pubmed: 31554344
J Cell Mol Med. 2016 Jan;20(1):157-69
pubmed: 26515425
Cells. 2019 Nov 27;8(12):
pubmed: 31783568
Biofactors. 2020 Jan;46(1):106-117
pubmed: 31625201
J Cell Mol Med. 2019 Feb;23(2):1581-1592
pubmed: 30585395
J Orthop Res. 2018 Nov;36(11):2823-2829
pubmed: 29873411
J Cell Sci. 2001 Nov;114(Pt 21):3813-22
pubmed: 11719548
Cell Mol Immunol. 2004 Apr;1(2):95-104
pubmed: 16212895
J Cell Biochem. 2018 Nov;119(10):7944-7958
pubmed: 29143973
Cell Transplant. 2015;24(10):2065-76
pubmed: 25333453
Nat Immunol. 2011 Jun 26;12(8):796-803
pubmed: 21706005
BMC Med Genet. 2018 Jul 18;19(1):119
pubmed: 30021560
Cytotherapy. 2015 Feb;17(2):128-39
pubmed: 24856898
Int J Mol Sci. 2020 Feb 26;21(5):
pubmed: 32111031
J Cell Mol Med. 2014 Aug;18(8):1631-43
pubmed: 24894806
Matrix Biol. 2004 Oct;23(6):381-91
pubmed: 15533759
Placenta. 2016 Dec;48:99-103
pubmed: 27871479
Genes Immun. 2012 Jan;13(1):1-13
pubmed: 22048454
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Stem Cells Transl Med. 2020 Sep;9(9):1023-1035
pubmed: 32452646
Stem Cells Transl Med. 2016 Nov;5(11):1473-1484
pubmed: 27405780
J Clin Med. 2019 Mar 28;8(4):
pubmed: 30925656
Arthritis Res Ther. 2014 Feb 27;16(1):R58
pubmed: 24572376
Cytotherapy. 2012 Feb;14(2):153-61
pubmed: 21954836
Stem Cells Dev. 2016 Apr 15;25(8):610-21
pubmed: 26914245
Cell Transplant. 2018 Jan;27(1):45-54
pubmed: 29562776
J Orthop Res. 2005 Jan;23(1):84-92
pubmed: 15607879
Clin Exp Rheumatol. 2015 Jul-Aug;33(4):484-90
pubmed: 25962385
J Exp Med. 2012 Aug 27;209(9):1655-70
pubmed: 22891274
Cells. 2020 May 09;9(5):
pubmed: 32397409
Nat Rev Immunol. 2008 Jul;8(7):533-44
pubmed: 18551128
Pharmaceutics. 2020 Apr 11;12(4):
pubmed: 32290510
Stem Cell Res Ther. 2020 Apr 28;11(1):165
pubmed: 32345351
Sci Rep. 2018 Apr 11;8(1):5810
pubmed: 29643421
Front Immunol. 2017 Aug 31;8:1062
pubmed: 28912781
Arthritis Res Ther. 2016 Nov 18;18(1):269
pubmed: 27863509
Cell Reprogram. 2012 Aug;14(4):334-41
pubmed: 22816556
Int J Biochem Cell Biol. 1996 Jun;28(6):619-37
pubmed: 8673727
J Tissue Eng Regen Med. 2018 Apr;12(4):1097-1110
pubmed: 29131526
BMC Musculoskelet Disord. 2020 Feb 6;21(1):78
pubmed: 32028937
Cytotherapy. 2017 Jul;19(7):784-797
pubmed: 28457740
J Orthop Res. 1996 May;14(3):370-6
pubmed: 8676248
PM R. 2017 Dec;9(12):1236-1243
pubmed: 28483683

Auteurs

Enrico Ragni (E)

IRCCS Istituto Ortopedico Galeazzi, Laboratorio di Biotecnologie Applicate all'Ortopedia, Milan, Italy.

Andrea Papait (A)

Centro di Ricerca E. Menni, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Department of Life Science and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.

Carlotta Perucca Orfei (C)

IRCCS Istituto Ortopedico Galeazzi, Laboratorio di Biotecnologie Applicate all'Ortopedia, Milan, Italy.

Antonietta Rosa Silini (AR)

Centro di Ricerca E. Menni, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.

Alessandra Colombini (A)

IRCCS Istituto Ortopedico Galeazzi, Laboratorio di Biotecnologie Applicate all'Ortopedia, Milan, Italy.

Marco Viganò (M)

IRCCS Istituto Ortopedico Galeazzi, Laboratorio di Biotecnologie Applicate all'Ortopedia, Milan, Italy.

Francesca Libonati (F)

IRCCS Istituto Ortopedico Galeazzi, Laboratorio di Biotecnologie Applicate all'Ortopedia, Milan, Italy.

Ornella Parolini (O)

Department of Life Science and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.

Laura de Girolamo (L)

IRCCS Istituto Ortopedico Galeazzi, Laboratorio di Biotecnologie Applicate all'Ortopedia, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH